AMIX Financials

Income Statement
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025
Revenue
Cost of Revenue
0
0
0
0
0
Gross Profit
Operating Expenses
2.7M
-18.1%
3.3M
-55.6%
7.5M
+120.2%
3.4M
+5.2%
3.3M
R&D
1.5M
-15.3%
1.7M
-27.2%
2.4M
+48.6%
1.6M
+2.6%
1.6M
SG&A
1.3M
-21.1%
1.6M
-68.7%
5.2M
+182.7%
1.8M
+7.6%
1.7M
Operating Income
-2737000
+18.1%
-3343000
+55.6%
-7534000
-120.2%
-3421000
-5.2%
-3252000
EBITDA
-2734000
+18.1%
-3339000
+55.7%
-7532000
-120.4%
-3418000
-6.7%
-3204000
Net Income
-2666000
+18.2%
-3261000
+56.2%
-7451000
-123.3%
-3337000
-4.6%
-3191000
EPS (Basic)
$-4.91
+35.1%
$-7.56
+73.9%
$-28.98
-29.0%
$-22.47
+7.6%
$-24.33
EPS (Diluted)
$-4.91
+35.1%
$-7.56
+73.9%
$-28.98
-29.0%
$-22.47
+7.6%
$-24.33
Shares (Diluted)
542.6K
+27.2%
426.5K
+65.5%
257.7K
+74.3%
147.9K
+12.7%
131.1K
Autonomix Medical (AMIX) — Financials